Search results
Kenneth R. Chien (born 1951) is an American doctor and medical scientist who has been a research director at Karolinska Institute, in Stockholm, since 2013. Chien has several papers with over 1,000 citations and a h-index of 132. His area of expertise is cardiovascular science.
18 de abr. de 2024 · Stem cells, Developmental Biology, Heart Disease, Heart Development, Genetics, Biotechnology – Kenneth R. Chien's group. The work of the Chien lab has led to the identification of a high-resolution atlas of the progenitor cells that build the human heart, as well as the factors that control their fate, using multiple model systems ...
Articles 1–20. Dept of Cell and Molecular Biology, Karolinska Institutet - Cited by 73,672 - Heart Disease - Stem Cells - Regenerative Biology and Medicine - Biotechnology.
8 de mar. de 2016 · Kenneth R. Chien's 466 research works with 57,649 citations and 17,013 reads, including: Author Correction: Placental growth factor exerts a dual function for cardiomyogenesis and...
6 de dic. de 2021 · VEGFA mRNA induces cardiovascular regeneration by increasing the capillary density in the injured muscle 6. We investigated the therapeutic potential of VEGFA mRNA in mouse, rat and pig models of...
2 Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden. kenneth.chien@ki.se. PMID: 36329321. DOI: 10.1038/s41587-022-01491-z. Abstract. The extraordinary success of mRNA vaccines against coronavirus disease 2019 (COVID-19) has renewed interest in mRNA as a means of delivering therapeutic proteins.
3 de nov. de 2022 · Kenneth R. Chien. Nature Biotechnology 40 , 1586–1600 ( 2022) Cite this article. 80k Accesses. 121 Citations. 441 Altmetric. Metrics. Abstract. The extraordinary success of mRNA...
